BACKGROUND: After liver transplantation (LT), there are liver-related, infectious and cardiovascular complications that contribute to reduced graft survival. These conditions are associated with an increase in the Von Willebrand factor antigen (VWF-Ag), which was previously correlated with survival in cirrhotic patients. OBJECTIVE: Evaluate VWF-Ag as a predictive marker of re-transplantation-free survival in patients after LT. METHODS: We measured VWF-Ag in patients after first LT and then followed them prospectively with regard to the primary endpoint, namely re-transplantation-free survival. RESULTS: There were 6 out of 80 patients who died or received re-LT during follow-up. In these patients, the median VWF-Ag was 510.6%, which was significantly higher (p = 0.001) than in the patients who were alive at the end of follow-up (with a median VWF-Ag = 186.8%). At a cut-off of 286.8%, VWF-Ag was significantly correlated with re-transplantation-free survival (p < 0.001). VWF-Ag was independently associated with re-transplantation-free survival in a multivariate analysis; as was alkaline phosphatase (ALP), but not the model of end-stage liver disease (MELD) score, donor age, nor cold ischemia time. A score combining VWF-Ag and ALP showed an impressive capability in the receiver operating characteristic (ROC) analysis (with area under the curve (AUC) = 0.958) to distinguish between patients with regard to the primary endpoint. CONCLUSIONS: VWF-Ag is a non-invasive marker that can predict outcome in patients after LT. Its diagnostic performance increased when combined with ALP in a newly developed scoring system.
BACKGROUND: After liver transplantation (LT), there are liver-related, infectious and cardiovascular complications that contribute to reduced graft survival. These conditions are associated with an increase in the Von Willebrand factor antigen (VWF-Ag), which was previously correlated with survival in cirrhotic patients. OBJECTIVE: Evaluate VWF-Ag as a predictive marker of re-transplantation-free survival in patients after LT. METHODS: We measured VWF-Ag in patients after first LT and then followed them prospectively with regard to the primary endpoint, namely re-transplantation-free survival. RESULTS: There were 6 out of 80 patients who died or received re-LT during follow-up. In these patients, the median VWF-Ag was 510.6%, which was significantly higher (p = 0.001) than in the patients who were alive at the end of follow-up (with a median VWF-Ag = 186.8%). At a cut-off of 286.8%, VWF-Ag was significantly correlated with re-transplantation-free survival (p < 0.001). VWF-Ag was independently associated with re-transplantation-free survival in a multivariate analysis; as was alkaline phosphatase (ALP), but not the model of end-stage liver disease (MELD) score, donor age, nor cold ischemia time. A score combining VWF-Ag and ALP showed an impressive capability in the receiver operating characteristic (ROC) analysis (with area under the curve (AUC) = 0.958) to distinguish between patients with regard to the primary endpoint. CONCLUSIONS: VWF-Ag is a non-invasive marker that can predict outcome in patients after LT. Its diagnostic performance increased when combined with ALP in a newly developed scoring system.
Authors: Ton Lisman; Tamara N Bongers; Jelle Adelmeijer; Harry L A Janssen; Moniek P M de Maat; Philip G de Groot; Frank W G Leebeek Journal: Hepatology Date: 2006-07 Impact factor: 17.425
Authors: C Rupp; A Rössler; E Halibasic; P Sauer; K-H Weiss; K Friedrich; A Wannhoff; A Stiehl; W Stremmel; M Trauner; D N Gotthardt Journal: Aliment Pharmacol Ther Date: 2014-10-14 Impact factor: 8.171
Authors: A Maieron; P Salzl; M Peck-Radosavljevic; M Trauner; S Hametner; R Schöfl; P Ferenci; M Ferlitsch Journal: Aliment Pharmacol Ther Date: 2013-12-05 Impact factor: 8.171
Authors: W R Kim; J M Smith; M A Skeans; D P Schladt; M A Schnitzler; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2014-01 Impact factor: 8.086
Authors: Andreas Wannhoff; Oliver J Müller; Kilian Friedrich; Christian Rupp; Petra Klöters-Plachky; Yvonne Leopold; Maik Brune; Mirja Senner; Karl-Heinz Weiss; Wolfgang Stremmel; Peter Schemmer; Hugo A Katus; Daniel N Gotthardt Journal: PLoS One Date: 2014-11-14 Impact factor: 3.240
Authors: Elisabeth Hannah Adam; Madara Möhlmann; Eva Herrmann; Sonia Schneider; Kai Zacharowski; Stefan Zeuzem; Christian Friedrich Weber; Nina Weiler Journal: World J Gastroenterol Date: 2020-05-07 Impact factor: 5.742